Company / PP&E (Net)
Fortress Biotech, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$2.5M
FY2025
5-year range
$2.5M / $15.1M
FY2021-FY2025
Trend
-22.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 4 consecutive years, from $15M in FY2021 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -27.3%.
Declined from $7M to $3M over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -42.2%
- 5-Year CAGR
- -27.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- Fortress Biotech, Inc.'s pp&e (net) has declined for 4 consecutive years.
- 5-year CAGR of -27.3%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 22.7% year-over-year.
- Peak pp&e (net) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | -22.7% |
| FY2024 | $3.3M | -49.9% |
| FY2023 | $6.5M | -50.0% |
| FY2022 | $13.0M | -13.6% |
| FY2021 | $15.1M | +21.2% |
| FY2020 | $12.4M | +0.0% |
| FY2019 | $12.4M | +3.4% |
| FY2018 | $12.0M | +401.4% |
| FY2017 | $2.4M | +105.9% |
| FY2016 | $1.2M | +276.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026